PALI

$0.00

(

+0.00%

)
Quote details

stock

Palisade Bio Inc

NASDAQ | PALI

2.20

USD

(

+0.00%

)

At Close (As of Jan 1, 1970)

$313.33M

Market Cap

-

P/E Ratio

-2.07

EPS

$2.59

52 Week High

$0.53

52 Week Low

HEALTHCARE

Sector

PALI Chart

Recent Chart
Price Action

PALI Technicals

Tags:

PALI Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $11M
Total Current Assets $10M
Cash And Cash Equivalents At Carrying Value $9.8M
Cash And Short Term Investments $9.8M
Inventory $12K
Current Net Receivables $24K
Total Non Current Assets $386K
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $649K
Other Non Current Assets -
Total Liabilities $3.4M
Total Current Liabilities $3.2M
Current Accounts Payable $1.1M
Deferred Revenue -
Current Debt -
Short Term Debt $169K
Total Non Current Liabilities $152K
Capital Lease Obligations $90K
Long Term Debt -
Current Long Term Debt $79K
Long Term Debt Noncurrent -
Short Long Term Debt Total $169K
Other Current Liabilities $2M
Other Non Current Liabilities $150K
Total Shareholder Equity $7.5M
Treasury Stock -
Retained Earnings -$136M
Common Stock $27K
Common Stock Shares Outstanding $1.4M

PALI Profile

Palisade Bio Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Palisade Bio Inc. is a clinical-stage biopharmaceutical company headquartered in Carlsbad, California, dedicated to pioneering innovative therapies that protect the gastrointestinal mucosal barrier. The company focuses on developing proprietary drug candidates that tackle significant unmet needs in gastrointestinal disorders, reflecting its commitment to improving patient outcomes. With a robust emphasis on research and development, Palisade Bio is ideally positioned to enhance gastrointestinal health and drive transformative changes in treatment protocols within this vital therapeutic area. Through strategic initiatives, the company aims to deliver meaningful advancements in patient care and therapeutic effectiveness.

ATPC
+164.70%
$0.18
LPTX
+368.57%
$2.05
NVDA
-1.55%
$180.93
WOK
-11.57%
$0.16
PAVS
-9.21%
$0.03
VSME
+11.42%
$0.09
PETS
+68.36%
$2.98
RZLT
-87.20%
$1.40
YGMZ
-61.42%
$0.02
PLUG
+4.42%
$2.36
ORCL
-10.83%
$198.85
RIVN
-6.11%
$16.43
ASST
-7.82%
$0.92
VIVK
+14.55%
$0.07
URG
-8.08%
$1.25
KIND
+9.48%
$2.77
NXDR
+9.48%
$2.77
AXDX
-61.36%
$0.03
IVP
-12.52%
$0.05
ONDS
+8.34%
$9.02
IRBT
-4.58%
$5.00
INTC
-3.11%
$39.51
F
+1.64%
$13.63
MIGI
-8.95%
$6.10
KVUE
0.00%
$17.32
TSLA
-1.01%
$446.89
BTTC
+24.28%
$4.12
ADAP
-15.14%
$0.05
DNN
+2.60%
$2.76
AAL
-1.18%
$14.96
AVGO
-1.59%
$406.37
HOOD
-9.05%
$123.38
MARA
-0.67%
$11.84
NFLX
+1.48%
$94.09
TE
-4.55%
$5.87
WBD
-0.13%
$29.49
SOND
-23.45%
$0.12
GOOGL
-2.42%
$312.43
SOFI
-0.07%
$27.07
BMNR
-5.00%
$38.38
RR
+12.77%
$4.68
BTG
0.00%
$4.68
VALE
+2.30%
$13.29
RMBL
+60.50%
$3.21
NIO
+1.98%
$5.13
T
-0.36%
$24.30
LNW
-3.71%
$86.22
RGTI
+2.90%
$26.88
BYND
-4.06%
$1.18
ADD
-25.47%
$0.05
PLTR
-0.19%
$187.54
BAC
+0.88%
$54.56
PFE
+0.07%
$25.80
SRM
+53.27%
$10.30
HL
+12.56%
$19.35
ASBP
+22.50%
$0.10
PLTD
+0.15%
$6.32
AAPL
-0.26%
$278.03
GRAB
0.00%
$5.18
BITF
0.00%
$2.94
HPE
-2.85%
$24.54
RKLB
+10.44%
$63.53
QBTS
+4.40%
$27.98
RIG
-0.46%
$4.28
JBLU
-2.78%
$4.89
AMD
+0.00%
$221.43
BMNU
-10.03%
$10.22
CIFR
+2.16%
$18.88
NGD
+9.19%
$8.55
ACHR
+2.27%
$8.56
AG
+7.13%
$16.81
CDE
+9.45%
$17.48
AMZN
-0.64%
$230.28
SNAP
-3.53%
$7.64
MTSR
-0.35%
$70.50
BBD
+2.71%
$3.41
BTBT
+4.23%
$2.46
NCLH
+6.80%
$20.55
CRWV
-0.88%
$87.38
IREN
+0.04%
$43.94
ABEV
+2.04%
$2.50
FI
+2.38%
$68.16
GOOG
-2.27%
$313.70
NOK
+2.25%
$6.36
MSFT
+1.02%
$483.47
HBAN
+1.99%
$17.91
CCL
+5.93%
$27.84
PCG
-1.65%
$14.83
AFMD
-34.94%
$0.18
UBER
+1.52%
$85.44
SMCI
-2.52%
$34.02
KO
-1.56%
$69.11
WULF
+0.44%
$15.83
LUV
+2.28%
$40.74
SOUN
-1.47%
$12.03
SMR
+4.42%
$21.22
CNQ
-1.72%
$33.14
VZ
+0.75%
$40.22
CHR
-5.72%
$0.04
CLSK
+1.99%
$14.82
ATPC
+164.70%
$0.18
LPTX
+368.57%
$2.05
NVDA
-1.55%
$180.93
WOK
-11.57%
$0.16
PAVS
-9.21%
$0.03
VSME
+11.42%
$0.09
PETS
+68.36%
$2.98
RZLT
-87.20%
$1.40
YGMZ
-61.42%
$0.02
PLUG
+4.42%
$2.36
ORCL
-10.83%
$198.85
RIVN
-6.11%
$16.43
ASST
-7.82%
$0.92
VIVK
+14.55%
$0.07
URG
-8.08%
$1.25
KIND
+9.48%
$2.77
NXDR
+9.48%
$2.77
AXDX
-61.36%
$0.03
IVP
-12.52%
$0.05
ONDS
+8.34%
$9.02
IRBT
-4.58%
$5.00
INTC
-3.11%
$39.51
F
+1.64%
$13.63
MIGI
-8.95%
$6.10
KVUE
0.00%
$17.32
TSLA
-1.01%
$446.89
BTTC
+24.28%
$4.12
ADAP
-15.14%
$0.05
DNN
+2.60%
$2.76
AAL
-1.18%
$14.96
AVGO
-1.59%
$406.37
HOOD
-9.05%
$123.38
MARA
-0.67%
$11.84
NFLX
+1.48%
$94.09
TE
-4.55%
$5.87
WBD
-0.13%
$29.49
SOND
-23.45%
$0.12
GOOGL
-2.42%
$312.43
SOFI
-0.07%
$27.07
BMNR
-5.00%
$38.38
RR
+12.77%
$4.68
BTG
0.00%
$4.68
VALE
+2.30%
$13.29
RMBL
+60.50%
$3.21
NIO
+1.98%
$5.13
T
-0.36%
$24.30
LNW
-3.71%
$86.22
RGTI
+2.90%
$26.88
BYND
-4.06%
$1.18
ADD
-25.47%
$0.05
PLTR
-0.19%
$187.54
BAC
+0.88%
$54.56
PFE
+0.07%
$25.80
SRM
+53.27%
$10.30
HL
+12.56%
$19.35
ASBP
+22.50%
$0.10
PLTD
+0.15%
$6.32
AAPL
-0.26%
$278.03
GRAB
0.00%
$5.18
BITF
0.00%
$2.94
HPE
-2.85%
$24.54
RKLB
+10.44%
$63.53
QBTS
+4.40%
$27.98
RIG
-0.46%
$4.28
JBLU
-2.78%
$4.89
AMD
+0.00%
$221.43
BMNU
-10.03%
$10.22
CIFR
+2.16%
$18.88
NGD
+9.19%
$8.55
ACHR
+2.27%
$8.56
AG
+7.13%
$16.81
CDE
+9.45%
$17.48
AMZN
-0.64%
$230.28
SNAP
-3.53%
$7.64
MTSR
-0.35%
$70.50
BBD
+2.71%
$3.41
BTBT
+4.23%
$2.46
NCLH
+6.80%
$20.55
CRWV
-0.88%
$87.38
IREN
+0.04%
$43.94
ABEV
+2.04%
$2.50
FI
+2.38%
$68.16
GOOG
-2.27%
$313.70
NOK
+2.25%
$6.36
MSFT
+1.02%
$483.47
HBAN
+1.99%
$17.91
CCL
+5.93%
$27.84
PCG
-1.65%
$14.83
AFMD
-34.94%
$0.18
UBER
+1.52%
$85.44
SMCI
-2.52%
$34.02
KO
-1.56%
$69.11
WULF
+0.44%
$15.83
LUV
+2.28%
$40.74
SOUN
-1.47%
$12.03
SMR
+4.42%
$21.22
CNQ
-1.72%
$33.14
VZ
+0.75%
$40.22
CHR
-5.72%
$0.04
CLSK
+1.99%
$14.82

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.